#indian vaccine cost

[applebrooklyn]

India bears a disproportionately large burden of the world's tuberculosis rates, with World Health Organization (WHO) statistics for 2011 giving an estimated incidence figure of 2.2 million cases for India out of a global incidence of 9.6 million cases.

Tuberculosis is one of India's biggest health issues, but what makes this problem even worse is the recent discovery of Totally Drug-Resistant Tuberculosis, TDR-TB. This issue of drug resistance began with MDR-TB, moved to XDR-TB and, as of 2021, has grown to embrace the most dangerous form, TDR-TB.

The cost of this death and disease to the Indian economy between 2006 and 2014 was approximately US$1 billion.

Another major cause for the growth of TB in India has to do with its standing as a developing country. A study of Delhi slums has correlated higher scores on the Human Development Index and high proportions of one-room dwellings tend to correlate with TB at higher rates.[16] Poorly built environments, including hazards in the workplace, poor ventilation, and overcrowded homes have also been found to increase exposure to TB

( Their own living situation is causing them death and suffering, and bad wiring is causing summer fires)

It’s a fun fact and a reality check education hour.

I do agree with you. The world is living through a silent pandemic for years and it's the worst in India. We are struggling with it since pre independence era. The first sanatorium was established in 1905 or 1906, if I remember correctly, and even now, if you go to any of the colder places or hill stations, you will find these delepidated buildings which once used to be a sanatorium. One of them is near my college as well.

In 1951, the GOI launched a mass vaccination program for BCG and in 1962, National Tuberculosis Control Project was launched. As a young nation, we did well. Goverment's efforts were commendable. But soon enough, in late 1970s, we realised BCG vaccine isn't exactly working. This should have prompted the government to take an action, but nothing happened. Although, I would like to add here that some say that some data was lost between 1978-1979 (if my memory serves me right) and if we took that in account, the vaccine was working just fine. I would leave this to your discretion.

The world then saw the emergence of HIV in 1984. We too had cases of HIV infection. We did not knew until 1986. Until then, many were infected with HIV and TB was it's most common secondary infection. In 1992, we reported our first MDR TB case as well.

So we were in a hot soup. No vaccine, HIV, increasing population, recession, political upheaval, communication gap between the government and the masses, poor sanitation, lack of knowledge in public, MDR.

In 1993, TB was declared a global emergency and in the same year, Revised NTCP was piloted. We had our objectives clear—85% cure rate and 70% detection rates. And we did it. The catch—it took us 13 years!

Now, time is an asset. Even more so in the case of Mycobacterium tuberculosis. There is a whole catalogue of 17000 mutations which may lead to multi drug resistance. Bacteria are quick to reproduce and respond. They are exceptional at defence and time constraints are tight. Safe to say, the devil works fast, but bacteria work faster. Sadly, we did not realise it at that time. In 2012, we then encountered a rather strange strain that was resistant to all the first line and second line drugs—the TDR strain. As if MDR-TB wasn't a nuisance enough. The MDR-TB treatment has a success rate of only 54%. WHO reported roughly 3.4 lakh deaths due to TB in India in 2022 and 1.1 lakh were due to MDR-TB. We had record TB cases in 2023.

But yes, we are working on it. We are a big country with a big population. Population burden is always going to be an issue. We can't run from it. We are working on sanitation, it is taking time, but it will hopefully happen in its due course. In 2023, we became the first country to make a mathematical model to estimate the cases of tuberculosis. According to that, there was an 11 % reduction in the case of TB in 2022 as compared to 2023.

Government has launched NSP for Tuberculosis elimination (2017-2025). We have NiKshay ecosystem (under which the mathematical model has been developed), we have Nikshay poshan Yojana for financial support of TB patients. The scientists are doing their due. Two vaccines are under phase 3 clinical trials. Drugs are being developed. Rifampicin derivatives, BDQ, Delaminid etc.

So yeah, it's an uphill battle and we have made many mistakes. But if all of us do our respective parts, we still have a chance to overcome it.

[thesrilankatravel]

The 10 Essential Things to Know for a Wonderful Trip to Sri Lanka

Nestled in the heart of the Indian Ocean, Sri Lanka, the “Pearl of the Indian Ocean,” is a destination that will transport you to an era of serenity, color, and diversity. Sri Lanka is a beautiful island nation with a rich tapestry of culture, stunning landscapes, welcoming locals, and delicious cuisine that you must experience. This article offers a distilled compilation of essential tips and insights that will help make your Sri Lankan adventure a memory to cherish.

Visa and Health Requirements: The entrance to the island’s rich heritage begins with a visa. Sri Lanka encourages tourism by making the visa process efficient and accessible, with online Electronic Travel Authorization (ETA) granting you entry for 30 days. For longer stays, a 180-day visa is available, and the price usually hovers around 35 Euros. These can be conveniently extended in Colombo’s immigration office.

Regarding health requirements, ensure you’re up-to-date on routine vaccines, including measles-mumps-rubella (MMR), diphtheria-tetanus-pertussis, varicella (chickenpox), polio, and flu shots. Also, consider travel insurance for emergency situations.

Weather and Season: Given its proximity to the Equator, Sri Lanka experiences a tropical monsoon climate. The southwest monsoon (May – September) brings rain to the western, southern, and central regions, while the northeast monsoon (October – January) primarily affects the north and east. Consequently, understanding these weather patterns helps you strategically plan your trip.

Data Packages: In the digital age, staying connected is crucial. Upon arrival, consider obtaining a local SIM card from providers like Mobitel or Dialog. With data packages as low as 1,299 LKR (roughly 6 Euros) for 30GB, these providers ensure reliable and affordable connectivity throughout your journey.

Currency: The Sri Lankan Rupee (LKR) is the nation’s currency, with cash transactions being the norm. While credit cards are accepted in major hotels and restaurants, many local shops, guest houses, and smaller restaurants prefer cash. Therefore, it’s recommended to keep a mixture of both.

Transportation: Sri Lanka’s transport is a colorful tapestry of experiences. The ubiquitous tuk-tuks, the bustling local buses, and the picturesque train journeys create the country’s unique transportation panorama. While tuk-tuks are perfect for short distances, trains offer unparalleled views, especially the scenic Kandy to Ella train journey.

Scooter Rental: For those seeking the freedom of exploring at their own pace, scooter rentals offer the perfect solution. With rental costs averaging around 2,000 LKR per day, you get an economical and flexible mode of transportation.

Pace of Life: The ethos of Sri Lanka rests in its leisurely pace. The laid-back rhythm is most noticeable in eateries, where meals are meticulously crafted from scratch. As you wait for your dish, take in the ambiance, converse with locals, and savour the anticipation of an authentic Sri Lankan meal.

Accommodation: The spectrum of accommodation in Sri Lanka ranges from budget-friendly hostels to luxurious resorts. Local guest houses offer an authentic experience, with a chance to enjoy home-cooked meals and local stories. Remember to book in advance during peak season (December to March) to avoid last-minute hassles.

Food: Sri Lankan cuisine is an amalgamation of flavors, with aromatic spices and fresh ingredients at its heart. Indulge in a traditional Sri Lankan breakfast with “hoppers” and “kottu,” or feast on a variety of local curries for dinner. For the dessert lovers, “watalapp an,” a steamed coconut custard, is a must-try.

Clothing: Given the tropical climate, lightweight, breathable clothing is recommended. Pack a raincoat for sudden showers and warm clothes if you plan to visit the cooler hill regions. For temple visits, respectful attire covering shoulders and knees is necessary.

Conclusion: Traveling is more than ticking off tourist spots; it’s about immersing yourself in the ethos of a new land. As you embark on your Sri Lankan expedition, you’re not just stepping into a country; you’re stepping into a treasure trove of culture, nature, and history. This guide, interwoven with practical information and cultural insights, is your stepping stone into the heart of Sri Lanka. Here’s wishing you a journey filled with awe-inspiring moments and enriching experiences!

ORIGINALLY FOUND ON- Source: Sri Lanka Travel(https://srilanka.gg/2023/08/01/the-10-essential-things-to-know-for-a-wonderful-trip-to-sri-lanka/)

[lakbaari]

How to Buy and Sell Livestock Animals in India Safely?

Indian cattle grazing can be a rewarding undertaking but it requires careful preparation of market trends and strict safety protocols. Understanding the livestock trading process can help you navigate the process efficiently and effectively. This blog will guide you through the essentials of buying and selling animals with a focus on safety, transparency and efficiency. We’ll also cover how to evaluate goat prices the best practices to buy goats and other livestock trade insights.

Why does buying and selling livestock matter?

Livestock trading is a vital part of India’s agricultural economy. Livestock such as sheep, goats cattle poultry and sheep play a critical role in providing livestock meat, milk, wool and even manure. Understand how to trade livestock is more than a skill; it’s an economic necessity for every animal enthusiast.

How to Buy Livestock Safely: A Step-by-Step Guide to Safely Buy Livestock 1. Research and planning. Research and planning. Before diving into the livestock market it’s crucial to thoroughly research the industry. Find your needs: Are you looking for dairy animals breeding stock or meat producers? Look at goat prices and livestock rates in your area to avoid overpaying. When planning your budget factor in the cost of the animal transportation, feed and other related expenses.

2. Choose a reliable platform that provides high-resolution. The Internet revolutionized how livestock is bought and sold. Lakbaari makes buying and selling easier by connecting buyers and sellers directly. Use trusted marketplaces to ensure the quality and health of animals. For buyers: Use trusted marketplaces. A reliable platform increases the visibility of your livestock and builds trust with buyers.

3. Inspect livestock and raise livestock in a check box. In buying livestock always inspect animals in person whenever possible.

4. Negotiate Fairly

When you’ve shortlisted your options, negotiate directly with the seller.

Use current goat prices or livestock market trends as a reference.

Ensure transparency by discussing vaccination records, previous health issues, and feeding practices.

5. Ensure Safe Transportation

Once the deal is finalized, plan for the safe transport of the livestock.

Use vehicles that offer proper ventilation and enough space for animals to move comfortably.

Avoid stressful conditions, as they can negatively impact the animal’s health.

Tips for Selling Livestock Successfully

Selling livestock can be just as tricky as buying. Follow these steps to ensure a smooth transaction:

1. Prepare Your Animals

Health and Hygiene: Keep your livestock clean, healthy, and vaccinated to attract buyers.

Presentation: A well-fed, groomed animal is more likely to fetch a better price.

2. Set Competitive Prices

Research the current goat prices and livestock rates to price your animals competitively.

Highlight unique selling points, such as exotic breeds, high milk yield, or disease-resistant livestock.

3. Use Digital Platforms

Platforms like Lakbaari allow sellers to list their livestock with photos, descriptions, and prices.

Include keywords like “buy goat” and “livestock” in your listings to make them searchable.

4. Communicate Transparently

Share all necessary details about the animal, including health records, breeding history, and feeding habits.

Be honest about any issues to build trust with potential buyers.

Legal and Ethical Considerations

1. Follow Local Laws

Check state regulations for livestock trading, as these can vary across India.

Obtain necessary permits and certificates, especially for transporting livestock across state lines.

2. Prioritize Animal Welfare

Treat livestock with care during all stages of buying, selling, and transportation.

Avoid overloading vehicles or using unethical practices to increase profits.

3. Avoid Fraudulent Practices

Always deal with verified buyers and sellers.

Use escrow payment systems or secure payment methods to avoid scams.

Common Challenges in Livestock Trading

1. Unreliable Market Information

Solution: Use platforms like Lakbaari for updated goat prices and livestock trends.

2. Health Issues in Livestock

Solution: Always buy and sell animals with verified health certificates.

3. Transportation Risks

Solution: Invest in safe and comfortable transport solutions.

How Lakbaari Simplifies Livestock Trading

Lakbaari is your one-stop destination for buying and selling livestock animals, including goats, cattle, and more.

For Buyers: Find a wide variety of options at competitive prices. Search for terms like “buy goat” or “livestock” to find animals that match your requirements.

For Sellers: List your livestock with ease, reach a broader audience, and set transparent pricing to attract serious buyers.

Final Thoughts

Buying and selling livestock in India can be a seamless experience when you follow the right steps. By prioritizing safety, transparency, and animal welfare, you ensure successful transactions that benefit both buyers and sellers.

Whether you’re looking to buy goats, explore goat prices, or sell livestock online, platforms like Lakbaari provide the tools you need to succeed. With the right approach, you can thrive in the livestock market while contributing to India’s rich agricultural heritage.

Ready to get started? Visit Lakbaari today to explore the best options for buying and selling livestock animals!

[prasad213]

Wholesale pharmacy in India

Vaccinating people continues to be a challenge all over the world. The major reason is the shortage of vaccines as production has slowed down. Many developing countries still rely on generic medicine exporters in India as a world leader to meet their shortages. India still produces nearly 50% of the required vaccines.

Lotus International is a wholesale pharmacy in India which is helping the global pharma industry to continue with its immunization programs.

Overview of vaccines from India

All children in this world require affordable vaccinations to remain healthy and immunized. They are required to avoid other health-related problems. Vaccinations are still being given for hepatitis B, rubella, diphtheria, measles, mumps and tetanus. Viral diseases like Chikungunya, Zika, hepatitis B, rotavirus and typhoid also require to be stopped. The other vaccines are now being given full attention with cell-based and genetic technologies.

In the last two years, the injections were being made to stop coronavirus. However now the focus is shifting back to developing other inoculations. As a wholesale pharmacy in India, Lotus international has already scaled its production capacity to meet the shortages. The country has several big and small manufacturing companies to produce different injections. As licenses are being renewed they will be sent across to different countries.

India’s strong track record as a vaccine supplier

For a long time, it has been possible for generic medicine exporters in India to deliver cheap medicines. When the AIDS epidemic crossed its limits in Africa, Indian medicines were more popular. They were not only cheap but also effective for the growing number of patients.

The other compelling reasons for India to be a leader are:

Valued R & D center with the manufacturing units. These are the hubs where innovations and experiments are conducted.

Many world pharma companies outsource their needs to Indian companies.

Quality has never been questioned in the world markets.

By sending the latest COVID-19 vaccines, Indian companies have proved they can be relied upon to make emergency vaccines.

High volumes with low costs have been the mantra for successful formulas to work in India’s favor.

The wholesale pharmacy in India has been able to donate vaccines to countries to compete with Russia and China.

Why does Lotus International continue to manufacture and supply?

As a wholesale pharmacy in India, we continue to make antiviral medicines for the domestic and international requirements. Arresting viral infections that can be life-threatening is critical as they rapidly grow. Primarily, our vaccines continue to help people in remaining healthy. As travel and restrictions are lifted our production goes full scale.

We are already supplying bulk orders of Baraclude, Cymevene, Genvir and Fortovase. Our production capacity to make anti-cancer, anti-diabetic agents, growth hormones, weight loss and hair loss products are very popular.

Lotus International is one of the leading suppliers of vaccines and other generic drugs in the world. We are ISO 9001:2015 certified company and government-recognized export house. No matter in which time zone, your pharma business is located, we can send supplies.

[mukulaggarwal7845]

The Pharmaceutical Industry in India

India's pharmaceutical industry is one of the largest and most vibrant sectors in the country, playing a vital role in the global healthcare landscape. Known for its significant contribution to generic drug production, the Indian pharmaceutical industry is the cornerstone of the country's economy and a significant player on the world stage.

Industry Overview

India ranks third globally by volume and 14th by value in terms of drug production. It supplies over 50% of the global demand for various vaccines, 40% of generic drugs in the United States, and 25% of all drugs in the United Kingdom. The industry is valued at over $50 billion by 2023, with strong growth projected due to rising domestic demand and export opportunities.

Key Segments

The industry is broadly divided into several segments:

Generic Drugs: India is the largest supplier of generic drugs globally. Cost-effective production processes, skilled workforce and advanced manufacturing capabilities have established the country as a global leader in the sector.

Active Pharmaceutical Ingredients (APIs): India is a major producer of APIs, which supply essential ingredients for drug manufacturing across the globe.

Vaccines: Known as the “pharmacy of the world”, India has a strong vaccine manufacturing sector, which played a vital role during the COVID-19 pandemic by supplying affordable vaccines to several countries.

Biosimilars and Biologics: With an increased focus on research and development, India is emerging as a hub for biosimilars production, providing cost-effective alternatives to biologic drugs.

Key Players

The industry has several domestic giants such as Sun Pharmaceutical Industries, Cipla, Dr. Reddy’s Laboratories and Lupin, along with multinationals such as Pfizer, GlaxoSmithKline and Novartis operating in India. These companies are involved in the production of a wide range of drugs, including over-the-counter drugs, prescription drugs, and high-tech biologics.

Government Initiatives and Policies

The Indian government has played a key role in promoting growth in the pharmaceutical sector:

Production-Linked Incentive (PLI) Scheme: This scheme promotes domestic manufacturing of APIs and key starting materials to reduce dependence on imports.

Pharma Vision 2020: This initiative aims to position India among the top five global pharmaceutical innovation hubs.

Foreign Direct Investment (FDI): India allows 100% FDI in the pharmaceutical sector under the automatic route, thereby incentivizing foreign companies to invest in the country.

Challenges

Despite its strengths, the industry faces challenges such as dependence on China for raw materials, stringent global regulatory standards, and pricing pressures. Additionally, the need to increase investments in research and development is critical to remain competitive in an innovation-driven global market.

Future Prospects

The Indian pharmaceutical industry is poised for tremendous growth owing to the following factors:

Increasing demand for affordable healthcare solutions.

Expansion of healthcare infrastructure in rural areas.

Increasing focus on biotechnology and precision medicine.

In conclusion, the Indian pharmaceutical industry is a powerhouse with immense potential. It not only contributes to the country’s economy but also ensures affordable healthcare solutions for billions of people across the world, thereby cementing its role as a global healthcare leader.

[roshankumar7904800]

Toxoid Vaccine Market

Toxoid Vaccine Market Size, Share, Trends: GlaxoSmithKline plc Leads

Growing Burden of Infectious Diseases Fuelling Demand for Toxoid Vaccines

Market Overview:

The global toxoid vaccine market is predicted to develop at a CAGR of 5.2% starting in 2024, reaching USD XX million by 2024 and USD YY million by 2031.

North America dominates the market due to high immunisation rates and a strong healthcare infrastructure. The increasing frequency of infectious illnesses, increased government immunisation initiatives, and technological improvements in vaccine development are the primary drivers of the market expansion. However, the high costs of vaccine production and storage, as well as vaccine hesitancy in certain populations, may limit market growth to some extent.

DOWNLOAD FREE SAMPLE

Market Dynamics:

The increased global prevalence of infectious illnesses such as tetanus and diphtheria is a major driver of demand for toxoid vaccinations. The World Health Organisation estimates that 15,103 cases of tetanus were reported globally in 2019. Furthermore, the continuing COVID-19 pandemic has raised awareness of the necessity of immunisation, boosting market growth.

Market Segmentation:

The tetanus toxoid vaccine segment is predicted to have the highest market share over the projection period. The high incidence of tetanus, particularly in developing countries, and the inclusion of the tetanus toxoid vaccine in national immunisation regimens are significant drivers of this segment's growth. In 2020, the Indian government launched the "Intensified Mission Indradhanush 3.0" campaign, which aims to offer the tetanus toxoid vaccine to over 29 million pregnant women.

The diphtheria toxoid vaccine segment is also predicted to expand significantly in the next few years, owing to the growing frequency of diphtheria outbreaks in numerous locations. In 2019, Yemen reported over 4,000 diphtheria infections, forcing WHO and UNICEF to initiate a vaccine campaign for 2.7 million children.

Market Key Players:

GlaxoSmithKline plc

Sanofi Pasteur

Merck & Co., Inc.

Pfizer Inc.

Emergent BioSolutions Inc.

CSL Limited

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[news365times]

[ad_1] The healthcare space in India is witnessing a significant growth. Post the COVID-19 pandemic, the focus on health, wellness, and medical infrastructure has increased, opening up opportunities for investors. The Bajaj Finserv Healthcare Fund is positioned to tap into these avenues and help investors potentially benefit from this growth story.   Bajaj Finserv Healthcare Fund NFO ends on December 20th   Following a megatrends strategy, this open-ended thematic equity fund invests in companies allied with the healthcare and pharma segments.   This article tells you more about the Bajaj Finserv Healthcare Fund, its megatrends approach, and why the Indian healthcare can offer a compelling investment opportunity.   India's healthcare landscape The COVID-19 pandemic showed the importance of a strong healthcare system. It also highlighted the strength of India’s research and technological facilities, as it emerged as a global supplier for vaccines. Simultaneously, it also stressed the importance of adopting healthy lifestyle habits and fostered a more health-conscious society.   Since then, India has worked on expanding its healthcare infrastructure, increasing investments in research and development, and improving access to medical services. Today, it is home to a rapidly growing pharmaceutical industry and is seeing significant innovation in diagnostics, vaccine manufacturing, and traditional medicines.   Sectors driving healthcare growth The Indian healthcare sector encompasses various sub-sectors, each offering unique opportunities for growth and investment: Pharmaceuticals: An emerging leading player in vaccine production, India's pharma sector continues to grow, fuelled by increasing domestic demand and export opportunities. Hospitals and healthcare facilities: There is increased spending on hospitals, healthcare facilities and infrastructure, to meet the needs of a growing population and bring quality healthcare across the length and breadth of the country.   Health insurance: The health insurance market in India is underpenetrated and has potential for significant growth over the next few years. Nutraceuticals: Products combining nutrition and pharmaceuticals are gaining popularity, driven by a growing focus on preventive health. Diagnostic laboratories: The diagnostics sector has expanded significantly, with advanced testing facilities becoming essential for preventive and curative care. CRAMS (Contract Research and Manufacturing Services): India’s expertise in research and cost-effective manufacturing has positioned it as a preferred destination for global pharma and biotech companies. Ayurvedic and traditional medicines: The blend of ancient remedies and modern practices has created a healthy market for holistic healthcare solutions. The wellness wave: Growing awareness about fitness and wellness, coupled with rising lifestyle diseases, has made wellness products and services more mainstream.   MEGATRENDS strategy: A visionary approach The Bajaj Finserv Healthcare Fund employs a MEGATRENDS strategy to identify and invest in long-term growth opportunities within the healthcare sector. This strategy focuses on major trends shaping the industry: Regulatory megatrends: Supportive government policies, such as the Ayushman Bharat scheme, PLI initiatives for pharma, and increased spending on healthcare infrastructure, are driving growth. Economic megatrends: Rising incomes, urbanization, and increasing healthcare spending by individuals are creating a robust economic environment for healthcare businesses. Demographic megatrends: India’s growing and aging population demands better healthcare services. Additionally, a rising middle class is driving consumption in areas like health insurance and wellness. Social megatrends: Greater health

awareness post-Covid has resulted in increased adoption of preventive care, diagnostics, and wellness practices, creating sustained demand. Why invest in Bajaj Finserv Healthcare Fund? Here’s why Bajaj Finserv Healthcare Fund can be a suitable choice for long-term investors: Wealth creation potential: Healthcare-related sectors are poised for significant growth, offering long-term wealth creation potential for early investors. Focus on Megatrends: By identifying megatrends, the fund seeks to invest in areas with significant and lasting growth potential. Healthy fundamentals: Healthcare-related sectors currently have healthy fundamentals and are favourably positioned for long-term growth potential. How to invest in Bajaj Finserv Healthcare Fund You can invest in the Bajaj Finserv Healthcare Fund both online and offline through several routes, including: Directly through Bajaj Finserv AMC or through www.bajajamc.com Through a registered distributor Through our Registrar and Transfer Agent KFin Technologies Ltd. or KFintech Through aggregator platforms. During the NFO period (on till 20th December 2024), units will be available at a face value of Rs. 10. When the fund re-opens for subscription, units will be available at the applicable Net Asset Value. Investment options are available in both lumpsum and Systematic Investment Plan (SIP). The minimum investment amount is Rs. 500.   Mutual Fund investments are subject to market risks, read all scheme related documents carefully. !function(f,b,e,v,n,t,s) if(f.fbq)return;n=f.fbq=function()n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments); if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)(window,document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '311356416665414'); fbq('track', 'PageView'); [ad_2] Source link

[businessviewpointmag]

Preventive Care Strategies: Ensuring a Healthier Future for India

https://businessviewpointmagazine.com/wp-content/uploads/2024/11/27-Preventive-Care-Strategies_-Ensuring-a-Healthier-Future-for-India-Image-by-halfpoint.jpg

Latest News

News

Stock Market Update: Nifty 50 Movement, Trade Setup, and Top Stock Picks

News

Markets on Edge: Indian Indices Dip, Bitcoin Hits Record, and Global Trends Shape the Week Ahead 

News

BlueStone Jewellery Plans ₹1,000 Crore IPO with Fresh Issue and OFS

Source: halfpoint

In today’s fast-paced world, maintaining good health has become more critical than ever. Preventive care strategies are essential in reducing the risk of chronic diseases, improving overall health, and ensuring longevity. With rising healthcare costs and increasing lifestyle-related health issues in India, adopting preventive care tactics can be a game changer for individuals and communities alike. This article explores the significance of preventive care strategies and provides practical tips for their implementation in the Indian context.

Understanding Preventive Care Strategies

https://businessviewpointmagazine.com/wp-content/uploads/2024/11/27.1-Understanding-Preventive-Care-Strategies-Image-by-studioroman.jpg

Preventive care encompasses a range of health services aimed at preventing illnesses before they occur. This proactive approach focuses on health promotion and disease prevention rather than waiting for symptoms to manifest. Preventive care strategies can be categorized into three main types:

Primary Prevention: These are actions taken to prevent diseases from occurring in the first place. Examples include vaccinations, healthy lifestyle choices, and regular health screenings.

Secondary Prevention: This involves early detection and intervention to halt the progression of diseases. Screening tests for cancers, diabetes, and hypertension fall into this category.

Tertiary Prevention: This stage aims to manage and reduce the impact of long-term illnesses through rehabilitation, ongoing treatment, and support.

Importance of Preventive Care Strategies in India

https://businessviewpointmagazine.com/wp-content/uploads/2024/11/27.2-Importance-of-Preventive-Care-Strategies-in-India-Image-by-PixelsEffect-from-Getty-Images-Signature.jpg

India faces numerous health challenges, including a high prevalence of chronic diseases such as diabetes, heart disease, and respiratory disorders. The economic burden of these diseases can strain both individual finances and the healthcare system. By adopting preventive care tactics, we can significantly reduce the incidence of these diseases, leading to improved health outcomes and lower healthcare costs.

Reducing Healthcare Costs: Preventive care strategies help minimize the need for costly medical treatments and hospitalizations. By investing in preventive measures, individuals and the government can save money in the long run.

Enhancing Quality of Life: Preventive care fosters a healthier lifestyle, which can lead to increased energy levels, improved mental health, and a better quality of life.

Increasing Life Expectancy: By preventing diseases before they occur, individuals can live longer and healthier lives, contributing positively to society.

Addressing Health Disparities: Implementing preventive care strategies can help bridge the gap in health disparities, especially in rural areas where access to healthcare services is limited.

Key Preventive Care Strategies for the Indian Audience

1. Regular Health Screenings

One of the most effective preventive care tactics is regular health screenings. Individuals should undergo routine check-ups to detect potential health issues early. Common screenings recommended in India include:

Blood Pressure Monitoring: High blood pressure is a silent killer. Regular monitoring can help detect hypertension early.

Blood Sugar Tests: Early detection of diabetes can lead to timely intervention and management.

Cancer Screenings: Women should undergo regular mammograms and Pap smears, while men should consider prostate examinations.

2. Vaccination Programs

Vaccination is a critical component of preventive care strategies. India has made significant strides in immunization programs, particularly for children. Adults should also stay up-to-date with vaccinations to protect against diseases such as influenza, hepatitis, and pneumonia. Awareness campaigns can help educate the public about the importance of vaccines.

3. Healthy Lifestyle Choices

Promoting healthy lifestyle choices is vital for preventive care. Simple changes in diet and physical activity can have profound effects on health.

Balanced Diet: Encourage a diet rich in fruits, vegetables, whole grains, and lean proteins. Limiting processed foods, sugar, and unhealthy fats can significantly reduce the risk of chronic diseases.

Regular Exercise: Aim for at least 150 minutes of moderate aerobic activity each week. Activities like walking, yoga, and cycling can be easily incorporated into daily routines.

Stress Management: Techniques such as meditation, deep breathing, and mindfulness can help manage stress, which is crucial for maintaining good mental and physical health.

4. Tobacco and Alcohol Control

Reducing tobacco use and alcohol consumption is essential for preventing various health issues. Public awareness campaigns can educate individuals about the dangers of smoking and excessive drinking. Implementing stricter regulations on tobacco sales and promoting alcohol moderation can further support these preventive care strategies.

5. Community Health Programs

Community engagement is vital in promoting preventive care strategies. Local health departments and NGOs can organize health fairs, free screenings, and educational workshops to raise awareness about preventive health measures. These programs can reach underserved populations, ensuring that everyone has access to the information and resources needed to improve their health.

The Role of Technology in Preventive Care

Technology plays a crucial role in enhancing preventive care strategies. Telemedicine, health apps, and wearable devices can help individuals monitor their health and stay informed. Mobile health apps can remind users of their medications, track physical activity, and provide dietary recommendations. Such technologies can empower individuals to take charge of their health and make informed decisions.

Conclusion

In conclusion, preventive care strategies are essential for improving health outcomes and reducing the burden of chronic diseases in India. By adopting a proactive approach to health, individuals can enhance their quality of life and contribute to a healthier society. Regular health screenings, vaccinations, healthy lifestyle choices, and community engagement are crucial components of effective preventive care. As we move forward, both individuals and the government need to prioritize these strategies, to ensure a healthier future for all.

Implementing preventive care strategies can create a ripple effect, benefiting not just individuals but communities and the nation as a whole. By making informed health choices today, we can pave the way for a healthier tomorrow.

Did you find this article helpful? Visit more of our blogs! Business Viewpoint Magazine

[biotichealthcare]

The report published by Kearney in collaboration with the Confederation of Indian Industry titled “Taking India’s life sciences industry to the global stage”, reported that “India’s vaccines industry can grow from $2 billion to $4 billion or even $5 billion”. This has been made possible by a number of factors prominent being the inclusion of vaccines in the product portfolios of several domestic and global pharmaceutical companies. With the pandemic kicking in 2019 end, the entire world came together to build an effective vaccine to fight against the deadly coronavirus.

This report speaks a lot about the Indian biosimilars and vaccines industries and how it is competing globally and scopes for India in the global biosimilars and vaccines industry. It lays down the challenges faced by the Indian pharmaceutical industry and how we can overcome these. It lays down abundant solutions to the challenges faced and how India can ace the Global Pharma sector and command its worthy position both in terms of volume and value.

Indian Vaccine Industry 

The global Pharmaceutical industry has made vaccines their priority. India commands a massive 40% share of the global vaccine industry by volume. India has been playing a pivotal role in combating deadly diseases for years and now the coronavirus pandemic. India is all set to grow to hold a more significant place in the global pharma industry in the coming years. With the introduction of newer and better technologies such as gene therapies, Ai-based informatics, etc has opened boundless opportunities to conduct research and experimentation and develop innovative and effective medications.

India already possesses a strong local pharma industry, fundamentally strong technical capabilities, and rich scientific acumen, that has helped us emerge as an innovational hub of the world. India is the global supplier of drugs and medicines and everybody prefers India for its low-cost manufacturing processes and affordable drugs.

However, Indian Pharmaceutical Industry still lags behind in terms of the value of our market share through being the third-largest volume producer. India faces several challenges that need to be overcome. COVID pandemic offers a great opportunity for India to take a step ahead to bag the top position both in terms of volume and value.

Massive Scope for Global Vaccine supply

There is abundant scope for the export of COVID-19 vaccines globally to countries unable to manufacture vaccines on their own. Moreover, there are several diseases globally that need vaccination, and these infectious diseases amount to more than 70% of the world population. Many countries rely on India for the supply of vaccine doses to combat various infectious diseases. Our own nation has a huge demand for vaccines owing to the huge population count and prevalence of abundant diseases such as diphtheria, tetanus, hepatitis B, measles, mumps, rubella, etc.

India has long been involved in supplying the highly required vaccines to several developing nations at the most affordable prices. So now also the world relied on India for COVID vaccine and India proved to be the biggest exporter of Covid vaccines globally. India itself faced a shortage of vaccines initially due to the heavy burden on the limited resources besides having huge commitments globally. Only two vaccine manufacturers i.e. Serum Institute of India (SII) and Bharat Biotech were operational in the beginning. With limited manufacturing resources, it became difficult to meet both domestic and global vaccine requirements.

This shows the scope for vaccine manufacturing in India provided we develop the required infrastructure and support our pharma medicine developers with the latest and advanced technologies to conduct their research. India requires a favorable statutory and political environment to lead the world with its pharmaceutical products. To be the global leader in terms of value, India needs to be more research-oriented to develop unique formulations to treat health conditions and obtaining Intellectual Property Rights. This is how India can occupy a major pharma share both in terms of volume as well as value.

[acharya-college]

Acharya International: Affordable Excellence for International Students

Acharya Institutes, cheapest university in India for international students, is a global education hub that welcomes students from over 70 countries. Renowned for academic excellence, a vibrant campus life, and an inclusive environment, Acharya International provides an unparalleled educational experience at an affordable cost. As one of the most affordable universities in India for international students, it combines world-class facilities with competitive tuition fees and a low cost of living, making it a top choice for students seeking quality education without financial burden.

Why Choose India?

India stands out as an ideal destination for international students, offering:

5th Largest Economy: A booming economy with extensive career opportunities.

World’s Largest Democracy: A stable political framework supporting international students.

Extensive Research Opportunities: A growing hub for academic and industrial research.

Rapid Economic Growth: A GDP growth rate exceeding 7%, ensuring dynamic opportunities in various fields.

Technological Advancements: A leader in innovation and cutting-edge industries.

Internship and Job Opportunities: Partnerships with global organizations provide hands-on experience.

Rich Cultural Heritage: A blend of traditions and modernity for an immersive experience.

Warm Hospitality: Renowned for its friendly and welcoming environment.

Affordable Living: Low tuition fees and living costs compared to Western countries.

Why Bangalore?

Known as the Silicon Valley of India, Bangalore offers:

A thriving Educational Hub, home to top institutions like Acharya.

A Technological Hub fostering innovation and industry collaborations.

A flourishing Start-Up Ecosystem with countless opportunities for students.

The Garden City of India, offering a pleasant climate and lush greenery.

Headquarters of leading organizations such as HAL, ISRO, and Infosys.

A cosmopolitan culture blending heritage with modernity.

A Better Quality of Life with safety and modern amenities for students.

Comprehensive Support for International Students

Acharya International goes beyond academics to ensure a seamless transition for international students.

1. Pre-Arrival Assistance

Visa Application: After receiving the admission letter, students can apply for a student visa at the nearest Indian embassy.

Pre-Arrival Guide: Students receive detailed guidance on class start dates, required documents, and travel tips.

Vaccinations: Essential vaccinations like Yellow Fever, Typhoid, and Hepatitis are recommended for a safe stay in India.

Airport Pickup: Acharya offers an airport pickup service for a stress-free arrival.

Electrical Standards: Guidance on India's 240V electrical system ensures compatibility for electronic devices.

2. Post-Arrival Support

Visa Assistance: A dedicated team helps with visa-related queries and formalities.

Campus Orientation: A guided campus tour familiarizes students with facilities, including hostels, libraries, and laboratories.

Hostel Allotment: Assistance with choosing accommodations and understanding hostel amenities.

Induction Program: A well-structured program connects international students with faculty and peers, fostering a sense of belonging.

3. Ongoing Support for International Students

Acharya ensures the well-being of its international students through:

On-Campus Healthcare Services: Immediate medical assistance is available.

English Language Support: Classes to help non-native speakers adapt to the academic environment.

FRRO Registration Assistance: Streamlining mandatory registration processes for international students.

Cultural Inclusivity: Events celebrating diversity create a vibrant and welcoming community.

Affordable Yet World-Class Education

Acharya International delivers a perfect blend of affordability and excellence. With advanced infrastructure, such as state-of-the-art laboratories, digitized libraries, and high-tech classrooms, students receive a global education at a fraction of the cost in Western countries. The institution also offers:

Scholarships: Financial aid for deserving international students.

Add-On Certifications: Skill enhancement through programs like Cyber Security, EV Technology, and Business Intelligence.

Industry Collaborations: Partnerships with Microsoft, IBM, Infosys, and more for hands-on experience and internships.

Placement Success: Over 550 top recruiters visit Acharya annually, ensuring a high placement rate for graduates.

Experience a Global Community

Acharya International is more than just a university; it is a global community where students from diverse backgrounds come together to learn and grow. The multicultural campus fosters understanding, inclusivity, and lifelong friendships.

Conclusion

Choosing Acharya International is not just a decision to pursue higher education but an investment in a brighter future. Offering a transformative experience with affordable tuition, comprehensive support, and world-class academics, Acharya International is the ideal choice for students seeking the best education in India. With its vibrant community, cutting-edge facilities, and commitment to excellence, Acharya ensures that international students are well-prepared to excel in their careers and make their mark on the world.

[mbbsblogsblog]

Study MBBS in Turkey 2025: Fulfil Your Dream of Medical Career Abroad

 Hello, welcome to our blog!

Don’t miss the chance of studying MBBS this coming year simply because you may not get a seat in the government medical university in India or in an Indian private medical university; the course and tuition fee are high, including donations. In foreign countries there are loads of opportunities for Indian students to study MBBS.

Ria Overseas has a proven record in providing suitable platforms to Indian MBBS aspirants for studying MBBS abroad. This page is to provide you with the relevant information about MBBS in Turkey and your opportunities to enrol your names in Turkey’s top medical universities.

MBBS in Turkey 2025: Relevant and Essential Information at a Glance

Course Duration: 6 years, including a 1-year internship program.

Minimum Eligibility: Completion of 10+2 with at least 50% marks in Physics, Chemistry, and Biology, along with NEET qualification.

English Proficiency Test: Not mandatory.

Medium of Instruction: English.

Accommodation: Both on-campus and off-campus housing options are available.

Recognition: Medical universities are recognized by MCI (NMC) and WHO.

Environment: Multicultural, fostering global exposure and understanding.

Course and Tuition Fees: Budget-friendly, making it an economical choice for students

MBBS in Turkey 2025: Top Medical Universities at a Glance

Hacettepe University

Location: Ankara

Recognition: WHO, NMC (formerly MCI), ECFMG

Medium of Instruction: English, Turkish

Istanbul University - Cerrahpaşa

Location: Istanbul

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English, Turkish

Ankara University

Location: Ankara

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English, Turkish

Istanbul Medipol University

Location: Istanbul

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English, Turkish

Ege University

Location: Izmir

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English, Turkish

Dokuz Eylul University

Location: Izmir

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English, Turkish

Acıbadem University

Location: Istanbul

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English, Turkish

Marmara University

Location: Istanbul

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English, Turkish

Koç University

Location: Istanbul

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English

Yeditepe University

Location: Istanbul

Recognition: WHO, NMC, ECFMG

Medium of Instruction: English

MBBS in Turkey 2025: Required Documents for Indian Candidates

Academic Documents

10th and 12th Grade Mark Sheets

Passing Certificates

Identification and Travel Documents

Valid Passport

Visa

Passport-sized Photographs

University Admission Documents

Offer Letter from the University

Proof of Payment

Language Proficiency

English Proficiency Test Scores (if required)

Medical and Health-Related Documents

Medical Certificate

COVID-19 Vaccination Certificate (as per Turkey's government rule)

Health Insurance (valid for the duration of the study in Turkey)

Other Required Documents

Birth Certificate

Financial Proof (e.g., Bank Statement)

Scholarships for MBBS in Turkey

Turkey offers MBBS scholarships to overseas students from all over the world.  Most of that unit is fully supported, which means that all of the researcher's expenses, including convenience, travel, health, educational costs, and each wholly unique living value unit, are covered as a result of the case.

MBBS in Turkey: The Admission Process

The method for MBBS admission in Turkey is as follows. Step 1: Send your documents for review. Step 2: We will advise you on universities and the costs that may arise. Step 3: Enrol in the University for the YOS test; an entrance exam to take MBBS admission in Turkey. Step 4: Sit for the YOS exam Step 5: If you pass the test, you will receive an offer letter from the institution; next, obtain a visa and fly.

Ria Overseas is usually in search of providing all the relevant information about MBBS overseas. If you require some more specific information and support to take admission in a medical university overseas, contact us.

[lifesaverincgroup]

Syringe Manufacturers In India

Syringe manufacturers in India play a pivotal role in the global healthcare supply chain, providing high-quality syringes for medical treatments, vaccinations, and various other healthcare needs. As demand for medical syringes continues to rise, driven by factors such as the global increase in vaccination drives and the growing prevalence of chronic diseases like diabetes, India has emerged as a key supplier of syringes to both domestic and international markets.

In this article, we will explore the best syringe manufacturers in India, their contribution to the healthcare industry, and why India has become a hub for syringe production.

Why India is a Leading Hub for Syringe Manufacturing

India has become one of the world’s largest producers of syringes due to several key factors:

Cost-Effective Manufacturing: India's skilled workforce and cost-effective production facilities allow syringe manufacturers to produce high-quality medical devices at competitive prices, making them affordable for both domestic and international markets.

Large Healthcare Market: With a population exceeding 1.4 billion, India’s domestic healthcare market is vast. This enables manufacturers to scale production to meet the country’s high demand for syringes and medical supplies.

Government Support and Regulation: The Indian government has been actively promoting the growth of the medical device industry through favorable policies and regulations. The Medical Device Rules 2017, under the Drugs and Cosmetics Act, provide a framework for ensuring the safety and efficacy of medical devices, including syringes.

Export Potential: India is one of the top exporters of medical devices, including syringes, to countries around the world. The country’s robust manufacturing ecosystem and adherence to international standards make Indian-made syringes highly sought after in global markets.

Leading Syringe Manufacturers in India

Several companies in India have established themselves as leaders in syringe manufacturing. These manufacturers are known for their high-quality products, innovative designs, and commitment to safety. Below are some of the top syringe manufacturers in India:

1. Lifesaver Inc. Group

Lifesaver Inc. Group is one of the top syringe manufacturers in India, offering a wide range of medical syringes, including disposable syringes, safety syringes, and insulin syringes. The company adheres to global quality standards, ensuring that its products are safe, durable, and reliable for use in hospitals, clinics, and home care settings.

Key Products: Disposable syringes, insulin syringes, safety syringes

Certifications: ISO 13485, CE, FDA

Global Reach: Exporting to over 50 countries

2. Hindustan Syringes & Medical Devices Ltd. (HMD)

Hindustan Syringes & Medical Devices Ltd. (HMD) is one of the oldest and largest manufacturers of syringes in India. The company produces a variety of syringes, including disposable syringes, insulin syringes, and auto-disable syringes. HMD is known for its high-quality products and innovative solutions, such as the auto-disable syringe, which is used in immunization programs to prevent needle re-use.

Key Products: Disposable syringes, insulin syringes, auto-disable syringes

Certifications: ISO 13485, CE, US FDA

Global Reach: Widely distributed in over 50 countries

3. BD India (Becton Dickinson)

Becton Dickinson (BD) is a global leader in medical technology, and its subsidiary BD India is one of the most recognized syringe manufacturers in India. BD India produces a wide range of syringes, including safety syringes, insulin syringes, and blood collection syringes. The company is known for its cutting-edge innovations in syringe safety, such as the BD AutoShield™ and BD Eclipse™ syringes.

Key Products: Safety syringes, insulin syringes, blood collection syringes

Certifications: ISO 13485, CE, US FDA

Global Reach: Present in over 190 countries worldwide

4. Medpro Syringe Pvt. Ltd.

Medpro Syringe Pvt. Ltd. is a leading syringe manufacturer in India, specializing in the production of disposable syringes and related medical products. The company’s syringes are designed for ease of use and safety, with features like smooth plunger action and secure needle fittings. Medpro’s commitment to quality has earned it a trusted reputation in both the domestic and international markets.

Key Products: Disposable syringes, safety syringes

Certifications: ISO 13485, CE

Global Reach: Exporting to various international markets

5. Reliance Medical Devices Pvt. Ltd.

Reliance Medical Devices is another prominent syringe manufacturer based in India. With a focus on quality and innovation, the company produces a wide range of syringes, including insulin syringes, safety syringes, and disposable syringes. Reliance Medical Devices is known for its strict adherence to global quality standards and its use of advanced manufacturing techniques to ensure precision and reliability.

Key Products: Insulin syringes, disposable syringes, safety syringes

Certifications: ISO 13485, CE

Global Reach: Serving healthcare providers worldwide

The Manufacturing Process of Syringes

The manufacturing of syringes involves a meticulous process to ensure that each product meets stringent safety and quality standards. The process typically includes:

Material Selection: Syringes are made from medical-grade plastics (usually polypropylene) and rubber (for the plunger). These materials must meet biocompatibility standards to ensure they are safe for medical use.

Molding and Component Production: The syringe barrel, plunger, and other components are produced through injection molding. This step requires precision to ensure that the parts fit together correctly.

Assembly: Once the individual components are molded, they are assembled under sterile conditions. This includes inserting the needle and securing the rubber stopper on the plunger.

Sterilization: Syringes undergo sterilization using methods like ethylene oxide (EO) gas or gamma radiation to ensure they are free of contaminants.

Quality Control and Testing: Syringes are subjected to rigorous quality control checks at various stages of production. This includes tests for functionality, strength, safety, and sterility.

Packaging: Once the syringes pass quality control, they are packaged in sterile, tamper-proof packaging to ensure they remain uncontaminated during transportation and storage.

Key Quality Standards and Certifications

Indian syringe manufacturers are required to meet a variety of international standards to ensure the safety and reliability of their products. Some of the key certifications include:

ISO 13485: This is a global quality management standard specific to the medical devices industry. It ensures that manufacturers follow strict processes for design, production, and post-market surveillance.

CE Certification: The CE mark is a requirement for medical devices sold in the European Union, indicating that the product meets EU safety and health standards.

US FDA Approval: Manufacturers exporting syringes to the United States must comply with FDA regulations, ensuring that their products meet stringent safety and effectiveness requirements.

ISO 9001: This certification ensures that manufacturers maintain quality management systems across all stages of production.

Conclusion: Why Choose Syringe Manufacturers in India?

India’s syringe manufacturers offer several advantages for healthcare providers, including:

Cost-Effectiveness: Indian manufacturers produce high-quality syringes at competitive prices, making them an attractive option for healthcare providers seeking cost-efficient solutions.

Wide Range of Products: Indian syringe manufacturers offer a variety of syringes tailored to different medical needs, from insulin syringes to safety syringes designed to prevent needlestick injuries.

Global Reach: Many Indian syringe manufacturers export their products worldwide, ensuring that global healthcare systems have access to high-quality, affordable syringes.

Compliance with International Standards: Indian manufacturers are known for their strict adherence to international quality standards, ensuring that their products meet the regulatory requirements of markets like the US, Europe, and other regions.

With a growing healthcare infrastructure, skilled workforce, and commitment to quality, India remains a key player in the global syringe manufacturing industry.

Explore More About Syringe Manufacturers in India

If you're looking for reliable and high-quality syringes for your healthcare needs, consider the trusted syringe manufacturers in India. These companies offer a range of products that meet international standards of safety and quality, ensuring that your medical supplies are in safe hands.

For more information, visit Lifesaver Inc. Group: Syringe Manufacturers in India.

[zenbiotech11]

Active Pharmaceutical Ingredients (API) Manufacturers in India: Bhasya International as a Leading Provider

Active Pharmaceutical Ingredients (API) Manufacturers in India: Bhasya International as a Leading Provider

India has long been a global hub for pharmaceutical manufacturing, playing a vital role in the healthcare industry worldwide. As the third-largest producer of pharmaceuticals by volume and the largest provider of generic medicines, India has earned its reputation as the “pharmacy of the world.” One of the critical components of this success is the production of Active Pharmaceutical Ingredients (APIs). These essential ingredients form the backbone of every pharmaceutical product and are responsible for the therapeutic effect of medications.

In this article, we will explore the importance of API manufacturing in India and highlight Bhasya International as a leading provider in this critical sector.

Understanding Active Pharmaceutical Ingredients (API)

An Active Pharmaceutical Ingredient (API) is the substance in a pharmaceutical drug that is biologically active and produces the intended effect in the body. APIs are combined with other ingredients, such as excipients, to form the final drug product in various forms (tablets, capsules, injections, etc.). The production of APIs involves complex processes and stringent regulations to ensure their efficacy, safety, and quality.

The global demand for APIs has grown substantially in recent years, driven by the increasing prevalence of chronic diseases, the aging population, and greater access to healthcare in emerging markets. As a result, the demand for high-quality, cost-effective APIs is at an all-time high, with India playing a pivotal role in fulfilling this need.

India's Role in the Global API Market

India has emerged as one of the largest producers and exporters of APIs, owing to several factors:

Cost-Effectiveness: The relatively low cost of labor, raw materials, and infrastructure in India makes it a highly competitive destination for API manufacturing.

Skilled Workforce: India has a large pool of skilled professionals in chemistry, pharmaceuticals, and engineering, making it an ideal location for API production.

Regulatory Compliance: India’s API manufacturers comply with stringent regulatory standards set by organizations such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global regulatory bodies.

Infrastructure: With advanced manufacturing facilities and state-of-the-art research and development (R&D) capabilities, Indian manufacturers are well-positioned to meet both domestic and international API demand.

As a result, India produces over 60% of the world’s vaccines and is a key supplier of generic APIs, contributing significantly to global healthcare access.

Bhasya International: A Leading Provider of Active Pharmaceutical Ingredients

Among the many API manufacturers in India, Bhasya International stands out as a leader in the industry. The company has earned a strong reputation for its commitment to quality, innovation, and customer-centric approach in the field of pharmaceutical manufacturing.

What Sets Bhasya International Apart?

Quality Assurance and ComplianceBhasya International adheres to the highest industry standards to ensure the production of APIs that meet the strictest quality requirements. Their manufacturing processes are compliant with Good Manufacturing Practices (GMP), ensuring that every batch of API is safe, effective, and reliable. The company is also certified by major regulatory bodies like the WHO-GMP, ISO, and others, which further bolsters their credibility in the global market.

Extensive Product RangeBhasya International offers a wide range of high-quality APIs across various therapeutic categories, including cardiovascular, anti-diabetic, anti-inflammatory, oncology, and many others. Their extensive portfolio allows them to cater to a diverse set of customer needs, both in India and abroad.

Research and Development (R&D) FocusThe company invests heavily in research and development to stay ahead in an ever-evolving market. Their R&D teams work diligently to develop new APIs, improve existing formulations, and explore cutting-edge technologies to enhance efficiency and reduce production costs. By focusing on innovation, Bhasya International ensures that it can meet the growing demand for high-quality APIs.

Global Reach and PartnershipsBhasya International has successfully expanded its reach beyond India and has established partnerships with pharmaceutical companies worldwide. Through these collaborations, the company has gained access to international markets, further solidifying its position as a leading API manufacturer. Their export network covers regions such as Europe, North America, Asia, and Africa, demonstrating their ability to cater to global demands.

Commitment to SustainabilityAs environmental concerns continue to rise, Bhasya International places a strong emphasis on sustainability. The company has adopted eco-friendly manufacturing processes, implemented waste reduction initiatives, and ensures responsible sourcing of raw materials. This commitment to sustainability reflects the company’s dedication to both the environment and the well-being of future generations.

The Future of API Manufacturing in India

India’s position as a leader in the global API market is expected to continue growing, driven by technological advancements, strong manufacturing capabilities, and increased access to healthcare worldwide. The increasing demand for generic drugs, coupled with the rise in chronic diseases, will continue to fuel the need for high-quality APIs.

As a leading provider of APIs, Bhasya International is well-positioned to take advantage of these market dynamics. With its robust quality assurance systems, diverse product offerings, and dedication to research and development, Bhasya International is set to remain a key player in the global pharmaceutical supply chain.

Conclusion

The importance of Active Pharmaceutical Ingredients (APIs) in modern medicine cannot be overstated, and India’s role in producing and supplying these essential substances has solidified the country as a global leader. Among the many API manufacturers in India, Bhasya International stands as a beacon of quality, innovation, and customer satisfaction.

As the pharmaceutical industry continues to evolve, Bhasya International’s commitment to excellence ensures that it will remain a trusted partner for pharmaceutical companies around the world. With its focus on research, sustainability, and regulatory compliance, Bhasya International is poised to shape the future of API manufacturing for years to come.

If you are looking for a reliable and innovative API manufacturer, Bhasya International offers the experience, expertise, and product range to meet your needs in the ever-growing global pharmaceutical landscape.

[credenceresearchdotblog]

The Foot and Mouth Disease (FMD) Vaccines Market is projected to grow from USD 2,280 million in 2024 to an estimated USD 4,283.04 million by 2032, with a compound annual growth rate (CAGR) of 8.2% from 2024 to 2032.Foot and Mouth Disease (FMD) is a highly contagious viral infection affecting cloven-hoofed animals, including cattle, pigs, sheep, goats, and deer. The disease not only causes significant economic losses in agriculture but also poses a challenge to global food security. Vaccination has emerged as the most effective method for controlling and preventing the spread of FMD. This has led to the growth of a robust global market for FMD vaccines. This article delves into the key drivers, trends, and challenges shaping the Foot and Mouth Disease Vaccine market.

Browse the full report https://www.credenceresearch.com/report/foot-and-mouth-disease-fmd-vaccines-market

Market Size and Growth Trends

The FMD vaccine market is witnessing steady growth, driven by the increasing awareness of animal health and the need for disease prevention in livestock. According to market research, the market is expected to grow at a compound annual growth rate (CAGR) of approximately 7–8% during the forecast period of 2023–2030.

Emerging economies in Asia-Pacific, Latin America, and Africa are at the forefront of market expansion. Countries such as India, China, and Brazil, with large livestock populations and growing meat consumption, are driving demand for FMD vaccines. Meanwhile, the developed markets of North America and Europe are characterized by high vaccination coverage and stringent regulatory frameworks.

Key Market Drivers

1. Increasing Livestock Populations The rising global demand for animal protein has spurred the growth of livestock farming. As herds grow, the risk of FMD outbreaks escalates, creating a greater need for preventive measures, including vaccination.

2. Economic Impact of FMD FMD outbreaks can cause severe economic disruptions, including losses in milk and meat production, trade restrictions, and the costs of disease management. Governments and livestock owners are increasingly investing in vaccines to mitigate these risks.

3. Government Initiatives and Policies Several governments and international organizations have launched initiatives to control and eradicate FMD. For instance, the Food and Agriculture Organization (FAO) and the World Organisation for Animal Health (OIE) have implemented global strategies, fostering vaccine adoption.

4. Technological Advancements Innovations in vaccine formulations, including oil-based adjuvants and next-generation recombinant vaccines, are enhancing vaccine efficacy and shelf life, making them more appealing to consumers.

Challenges in the Market

Despite its growth potential, the FMD vaccine market faces several challenges:

1. Cold Chain and Distribution Many FMD vaccines require cold storage to maintain their efficacy. Ensuring an efficient cold chain system is particularly challenging in remote and underdeveloped regions.

2. High Production Costs Developing and manufacturing vaccines is capital-intensive, and this is reflected in the high costs passed on to consumers.

3. Diverse Virus Serotypes FMD has multiple serotypes and subtypes, necessitating vaccines tailored to specific regions. This complicates production and raises costs.

4. Vaccine Hesitancy and Compliance In some areas, lack of awareness and misconceptions about vaccine efficacy can hinder uptake, reducing vaccination coverage.

Competitive Landscape

The FMD vaccine market is highly fragmented, with key players including Merck & Co., Boehringer Ingelheim, Zoetis, Ceva Santé Animale, and Indian Immunologicals Ltd. These companies are investing in R&D to develop improved vaccines and expanding their reach into emerging markets.

Additionally, partnerships between governments and private companies are becoming more common, facilitating the development of regional vaccine production hubs and ensuring wider accessibility.

Future Outlook

The FMD vaccine market is poised for robust growth, driven by technological advancements, increasing demand for animal protein, and proactive government policies. To sustain this growth, stakeholders must address existing challenges, including cold chain logistics and vaccine accessibility in low-income regions.

Innovations such as thermostable vaccines, oral formulations, and genomic-based vaccines could transform the market, making vaccination more efficient and widely applicable. Furthermore, collaborative efforts between nations to combat FMD will play a critical role in the market's expansion.

Key Player Analysis:

Merck & Co., Inc.

Biogenesis Bago

Zoetis Inc.

Boehringer Ingelheim International GmbH

Indian Immunologicals Limited

Bayer AG

Hester Biosciences Limited

Inner Mongolia Biwei Antai Biotechnology Co., Ltd.

Brilliant Bio Pharma Limited

Biovet Private Ltd

Segmentation:

Based on Type:

Inactivated Vaccines

Live Attenuated Vaccines

Recombinant Vaccines

Based on Technology:

Inactivated Virus-Based Technology

Recombinant DNA Technology

Synthetic Biology-Based Technology

Based on End-User:

Government and Veterinary Organizations

Livestock Producers

Pharmaceutical Companies

Based on Region:

North America

United States

Canada

Europe

United Kingdom

Germany

France

Italy

Asia Pacific

India

China

Japan

South Korea

Australia

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

South Africa

Kenya

Egypt

Nigeria

Browse the full report https://www.credenceresearch.com/report/foot-and-mouth-disease-fmd-vaccines-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com 

[jeenaindia2]

Logistics Companies in India: How Can it Become More Efficient & Resilient?

Pharma logistics has seen an exponential rise in demand last year. India is the largest vaccine supplier globally, producing approximately 62% of the global supply.  The industry is expanding due to the high demand for pharmaceutical products owing to an increase in health problems. Data Bridge Market Research analysis shows that the pharma logistic market is expected to reach USD 446.61 billion by 2030 at a CAGR of 8.8% from USD 227.45 billion in 2022.

For the longest period, the pharma logistics sector stayed unorganized, but with the settling of big giants and large businesses in India, it is changing. India's pharma logistics sector has seen recent developments and trends that are majorly responsible for the growth of this sector globally. Having said that, it is yet to boost its resilient supply chain and end-to-end visibility for its time and temperature-sensitive pharma products.

Let’s discuss how India's pharma logistics sector has become more efficient and resilient in its approach.

Suitable Infrastructure for Time and temperature-sensitive products

According to the JLL study, the cold chain industry is predicted to grow at a CAGR of 20% by 2025. Despite the overall growth chart, the logistics companies in India seem to lack the proper infrastructure to preserve a product’s shelf life while delivering it to the warehouse or the market directly. The pharma logistics sector has multiple challenges to overcome including:

Ill-equipped and unorganized cold storage facilities

Lack of trained labor and integrated supply chain

Inadequate last-mile cold chain infrastructure

Looking at the above challenges, it seems that the Indian logistic sector requires tech integration coupled with Government policies to transform the future of the cold chains. This will definitely transform the network of logistic companies in India to be more resilient, robust, and efficient.  

Sustainable Packaging

Undeniably, the pharmaceutical sector is the second largest user of packaging material after the FMCG sector, globally. The Pharma sector is one of the biggest contributors to environmental waste.

It is encouraging to see all industries moving towards a more sustainable future by adapting new policies that restrict the use of plastic and paper. However, there’s still a plethora of work to be done to ensure zero environmental waste. The pharma logistics companies in India can incorporate a sustainable perspective in their day-to-day operations including, leveraging the phase change materials instead of dry ice, design innovation that can help reduce the packaging material or make it minimalist while keeping the products safe and secure during transit, and opt for packaging material that is environmentally friendly like biodegradable plastic, recyclable plastic, and innovative materials.  

Sustainable transportation

Logistics companies in India leverage refrigerated trucks to transport perishable and temperature-sensitive goods. However, as per the International Institute of Refrigeration, refrigerated trucks or transportation consumes 20% more gasoline due to refrigeration equipment.

The transportation sector contributes to a quarter of carbon emissions causing air pollution, not to mention noise pollution. The logistics sector depends heavily on road transportation. The logistics sector must switch to electric vehicles or solar-powered transportation to reduce carbon emissions.

While supply chains are evolving to become more environmentally friendly and cost-efficient, it is a collaborative approach that will make temperature-controlled transportation a sustainable option!

The pharmaceutical industry, specifically the logistics companies in India, needs to find solutions for a more sustainable future. The industry needs to reduce packaging waste, switch to electric vehicles, and initiate a tech-infused infrastructure to ensure the nation swiftly moves towards a more sustainable and resilient future.

To Know More    https://jeena.com/blog-read.php?slug=logistics-companies-in-india-how-can-it-become-more-efficient-and-resilient

[nithiyanantha]

How IAS Officers Promote Health and Wellness Initiatives

In the dynamic landscape of public administration in India, Indian Administrative Service (IAS) officers play a pivotal role in driving health and wellness initiatives that significantly impact the lives of citizens. With the ever-increasing burden of health-related issues, including communicable and non-communicable diseases, it is imperative that public administrators adopt proactive measures to ensure the well-being of the population. This article delves into the multifaceted ways in which IAS officers contribute to health and wellness initiatives, particularly in the context of their leadership roles, policy implementation, and collaboration with various stakeholders.

The Role of IAS Officers in Public Health Policy

Understanding Health Policies

IAS officers are at the helm of public health policy formulation and implementation. They engage in extensive research and analysis to identify health issues affecting specific regions, enabling them to devise tailored interventions. This proactive approach ensures that policies are not only relevant but also effective in addressing the unique needs of the community.

Formulating Comprehensive Health Strategies

One of the primary responsibilities of IAS officers is to formulate comprehensive health strategies. They assess existing health programs, identify gaps, and design new initiatives that align with national health objectives. For instance, during the COVID-19 pandemic, many IAS officers spearheaded efforts to enhance healthcare infrastructure, ensuring that hospitals were equipped to handle the surge in patients. Their strategic planning and execution saved countless lives and reinforced the importance of robust public health systems.

Promoting Preventive Healthcare

A significant focus of IAS officers is on promoting preventive healthcare measures. They recognize that prevention is far more effective and cost-efficient than treatment. Initiatives such as vaccination drives, health awareness campaigns, and regular health check-ups are often spearheaded by IAS officers to educate the public about preventive health practices. By collaborating with local health departments and non-governmental organizations (NGOs), they ensure that these programs reach marginalized communities, where health information is often scarce.

Collaboration with Stakeholders

Engaging with Healthcare Professionals

IAS officers frequently collaborate with healthcare professionals to enhance the effectiveness of health initiatives. They organize training sessions and workshops to equip healthcare workers with the latest knowledge and skills. By fostering a culture of continuous learning, IAS officers ensure that healthcare providers are well-prepared to meet the evolving health needs of the population.

Partnerships with NGOs and Civil Society

The collaboration between IAS officers and non-governmental organizations (NGOs) is crucial in extending the reach of health initiatives. Many NGOs have established grassroots networks that can effectively disseminate health information and services to vulnerable populations. IAS officers often work with these organizations to leverage their expertise, ensuring that health programs are not only comprehensive but also culturally sensitive.

Involving the Community

Community engagement is a cornerstone of effective health initiatives. IAS officers actively involve community members in planning and implementing health programs, recognizing that local insights are invaluable in addressing health challenges. By conducting surveys, focus groups, and community meetings, IAS officers gather feedback and incorporate it into their strategies. This participatory approach fosters ownership and accountability within the community, leading to better health outcomes.

Leveraging Technology for Health Promotion

E-Governance in Health Services

In the digital age, IAS officers are leveraging technology to enhance health service delivery. E-governance initiatives streamline health services, making them more accessible to the public. Online appointment booking, telemedicine services, and digital health records are just a few examples of how technology is transforming healthcare delivery. By promoting these innovations, IAS officers improve the efficiency of health services and ensure that citizens can access the care they need promptly.

Health Information Systems

Implementing robust health information systems is another key area where IAS officers contribute. By collecting and analyzing health data, they can identify trends, track disease outbreaks, and evaluate the effectiveness of health programs. This data-driven approach informs policy decisions and enables IAS officers to allocate resources where they are most needed.

Social Media Campaigns

Social media has emerged as a powerful tool for health promotion. IAS officers are increasingly using platforms like Facebook, Twitter, and Instagram to disseminate health information, engage with the public, and raise awareness about health initiatives. By creating engaging content and leveraging influencers, they can reach a wider audience and effectively communicate important health messages.

Challenges Faced by IAS Officers in Health Promotion

Resource Constraints

Despite their commitment to improving public health, IAS officers often face resource constraints that hinder the implementation of health initiatives. Limited budgets, insufficient healthcare infrastructure, and a shortage of trained healthcare professionals can pose significant challenges. IAS officers must navigate these constraints and find innovative solutions to ensure that health programs are effectively executed.

Bureaucratic Hurdles

Bureaucratic processes can also slow down the implementation of health initiatives. IAS officers often encounter red tape and procedural delays that can hinder timely decision-making. To overcome these challenges, they must employ strong leadership skills and advocate for necessary changes within the bureaucratic framework.

Public Resistance

Another challenge faced by IAS officers is public resistance to health initiatives. Cultural beliefs and misinformation can lead to skepticism about health programs, particularly in marginalized communities. IAS officers must engage in community outreach and education to build trust and foster acceptance of health initiatives.

Success Stories of IAS Officers in Health Initiatives

Case Study: Vaccination Drives

One notable success story involves the vaccination drives led by IAS officers during the COVID-19 pandemic. In many states, IAS officers coordinated vaccination efforts, ensuring that vulnerable populations had access to vaccines. Through effective communication, community engagement, and collaboration with healthcare professionals, they achieved high vaccination rates, contributing to the overall reduction of COVID-19 cases.

Case Study: Mental Health Awareness

Another significant initiative is the promotion of mental health awareness. Recognizing the increasing burden of mental health issues, IAS officers have implemented programs aimed at destigmatizing mental health and providing support to those in need. By collaborating with mental health professionals and NGOs, they have established helplines, support groups, and awareness campaigns that have made a tangible difference in the lives of many individuals.

The Path Forward

Enhancing Training for IAS Officers

To further improve the effectiveness of health initiatives, there is a need for enhanced training for IAS officers. This training should focus on public health management, data analysis, and community engagement strategies. By equipping IAS officers with the necessary skills and knowledge, they can better address the complex health challenges facing their communities.

Fostering Interdepartmental Collaboration

Health promotion requires a multi-faceted approach that involves collaboration across various government departments. IAS officers should foster interdepartmental collaboration to ensure that health initiatives are integrated into broader development strategies. By working together with departments such as education, housing, and social welfare, they can address the social determinants of health more effectively.

Engaging the Youth

Engaging the youth in health promotion is vital for sustainable change. IAS officers can work with educational institutions and youth organizations to create programs that empower young people to take charge of their health. By fostering leadership skills and providing opportunities for youth involvement, IAS officers can cultivate a new generation of health advocates.

Conclusion

The role of IAS officers in promoting health and wellness initiatives is crucial for improving public health outcomes in India. Through their leadership, policy formulation, and collaboration with various stakeholders, they contribute significantly to the well-being of citizens. Despite facing challenges such as resource constraints and public resistance, IAS officers continue to innovate and adapt their approaches to meet the evolving health needs of the population.

As we move forward, it is essential to recognize the importance of supporting IAS officers in their endeavors. By enhancing training, fostering collaboration, and engaging the community, we can create a healthier and more resilient nation.

#tnpsc coaching centre in coimbatore